tiprankstipranks
Trending News
More News >
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
US Market

Y-Mabs Therapeutics (YMAB) Technical Analysis

Compare
507 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Y-Mabs Therapeutics’s (YMAB) Moving Averages Convergence Divergence (MACD) indicator is -0.18, suggesting Y-Mabs Therapeutics is a Sell.
Y-Mabs Therapeutics’s (YMAB) 20-Day exponential moving average is 4.42, while Y-Mabs Therapeutics’s (YMAB) share price is $4.25, making it a Sell.
Y-Mabs Therapeutics’s (YMAB) 50-Day exponential moving average is 4.96, while Y-Mabs Therapeutics’s (YMAB) share price is $4.25, making it a Sell.

Y-Mabs Therapeutics (YMAB) Pivot Points

May 06, 2025, 07:45 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.94
4.05
4.23
4.34
4.52
4.63
4.81
Fibonacci
4.05
4.16
4.23
4.34
4.45
4.52
4.63
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Y-Mabs Therapeutics (YMAB) Moving Averages

May 06, 2025, 07:45 PM
Period
Simple
Exponential
MA5
4.24Buy
4.26Sell
MA10
4.21Buy
4.30Sell
MA20
4.42Sell
4.42Sell
MA50
4.75Sell
4.96Sell
MA100
5.98Sell
6.27Sell
MA200
9.51Sell
8.77Sell
Y-Mabs Therapeutics’s (YMAB) 10-Day exponential moving average is 4.30, while Y-Mabs Therapeutics’s (YMAB) share price is $4.25, making it a Sell.
Y-Mabs Therapeutics’s (YMAB) 100-Day exponential moving average is 6.27, while Y-Mabs Therapeutics’s (YMAB) share price is $4.25, making it a Sell.
Y-Mabs Therapeutics’s (YMAB) stock price is $4.25 and Y-Mabs Therapeutics’s (YMAB) 50-day simple moving average is 4.75, creating a Sell signal.
Y-Mabs Therapeutics’s (YMAB) stock price is $4.25 and Y-Mabs Therapeutics’s (YMAB) 100-day simple moving average is 5.98, creating a Sell signal.
Y-Mabs Therapeutics’s (YMAB) stock price is $4.25 and Y-Mabs Therapeutics’s (YMAB) 200-day simple moving average is 9.51, creating a Sell signal.

Y-Mabs Therapeutics (YMAB) Technical Indicators

May 06, 2025, 07:45 PM
Name
Value
Implied Action
RSI (14)
44.83
Neutral
STOCH (9,6)
49.20
Neutral
STOCHRSI (14)
26.04
Neutral
MACD (12,26)
-0.18
Sell
ADX (14)
18.38
Buy
Williams %R
-74.38
Buy
CCI (14)
-13.44
Neutral
ATR (14)
0.37
-
Ultimate Oscillator
51.53
Neutral
ROC
-13.79
Sell
Y-Mabs Therapeutics’s (YMAB) Relative Strength Index (RSI) is 44.83, creating a Neutral signal.
Y-Mabs Therapeutics’s (YMAB) Trend Strength Indicator (ADX) is 18.38, creating a Buy signal.
Y-Mabs Therapeutics’s (YMAB) Commodity Channel Index (CCI) is -13.44, creating a Neutral signal.
Y-Mabs Therapeutics’s (YMAB) Price Rate of Change (ROC) is -13.79, creating a Sell signal.

FAQ

Is YMAB a Buy, Hold, or Sell?
Based on YMAB’s technical indicators, YMAB is a Sell.
    What is YMAB’s RSI (14)?
    YMAB’s RSI (14) is 44.83, which suggests YMAB is a Neutral.
      What is YMAB’s MACD?
      YMAB’s MACD is -0.18, which suggests YMAB is a Sell.
        What is YMAB’s 5-day moving average?
        YMAB’s 5-day moving average is 4.24, which suggests YMAB is a Buy.
          What is YMAB’s 20-day moving average?
          YMAB 20-day moving average is 4.42, which suggests YMAB is a Sell.
            What is YMAB’s 50-day moving average?
            YMAB’s 50-day moving average is 4.75, which suggests YMAB is a Sell.
              What is YMAB’s 200-day moving average?
              YMAB’s 200-day moving average is 9.51, which suggests YMAB is a Sell.
                What is YMAB’s Williams % R (14)?
                YMAB’s Williams % R (14) is -74.38, which suggests YMAB is a Buy.
                  What is YMAB’s CCI (14)?
                  YMAB’s CCI (14) is -13.44, which suggests YMAB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis